Home Applications 020763 Application 020763
Type NDA
Sponsor GLAXOSMITHKLINE LLC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 AMERGE NARATRIPTAN HYDROCHLORIDE TABLET;ORAL EQ 2.5MG BASE Yes Yes 002 AMERGE NARATRIPTAN HYDROCHLORIDE TABLET;ORAL EQ 1MG BASE Yes No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020763-001 AMERGE NARATRIPTAN HYDROCHLORIDE EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1998-02-10 N020763-002 AMERGE NARATRIPTAN HYDROCHLORIDE EQ 1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1998-02-10
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 3 of 3 · 90 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N020763-001 AMERGE EQ 2.5MG BASE TABLET / ORAL AB RLD, RS 1998-02-10 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N020763-002 AMERGE EQ 1MG BASE TABLET / ORAL AB RLD 1998-02-10 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N020763-001 AMERGE EQ 2.5MG BASE TABLET / ORAL AB RLD, RS 1998-02-10 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 N020763-002 AMERGE EQ 1MG BASE TABLET / ORAL AB RLD 1998-02-10 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N020763-001 AMERGE EQ 2.5MG BASE TABLET / ORAL AB RLD, RS 1998-02-10 e64feba35796…2022-09-29 23:25 UTC 2022-09 N020763-002 AMERGE EQ 1MG BASE TABLET / ORAL AB RLD 1998-02-10 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N020763-001 AMERGE EQ 2.5MG BASE TABLET / ORAL AB RLD, RS 1998-02-10 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N020763-002 AMERGE EQ 1MG BASE TABLET / ORAL AB RLD 1998-02-10 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N020763-001 AMERGE EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1998-02-10 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N020763-002 AMERGE EQ 1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1998-02-10 a50c72e98297…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 46 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 8 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0173-0561 AMERGE naratriptan hydrochloride GlaxoSmithKline LLC NDA Current 0173-0561 AMERGE naratriptan hydrochloride GlaxoSmithKline LLC NDA Current 0173-0561 AMERGE naratriptan hydrochloride GlaxoSmithKline LLC NDA Current 0173-0561 AMERGE naratriptan hydrochloride GlaxoSmithKline LLC NDA Current 0173-0562 AMERGE naratriptan hydrochloride GlaxoSmithKline LLC NDA Current 0173-0562 AMERGE naratriptan hydrochloride GlaxoSmithKline LLC NDA Current 0173-0562 AMERGE naratriptan hydrochloride GlaxoSmithKline LLC NDA Current 0173-0562 AMERGE naratriptan hydrochloride GlaxoSmithKline LLC NDA Current